Skip Navigation


JAC Advance Access originally published online on February 19, 2008
Journal of Antimicrobial Chemotherapy 2008 61(4):966-967; doi:10.1093/jac/dkn061
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/4/966    most recent
dkn061v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tsai, H.-C.
Right arrow Articles by Liu, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, H.-C.
Right arrow Articles by Liu, Y.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Letters to the Editor

Comment on: Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis

Hung-Chin Tsai1,2,*, Yao-Shen Chen1,3, Susan Shin-Jung Lee1,2 and Yung-Ching Liu1,2

1 Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan 2 National Yang-Ming University, Taipei, Taiwan 3 Institute of Environmental Education, National Kaohsiung Normal University, Kaohsiung, Taiwan


* Correspondence address. Section of Infectious Diseases and Department of Medicine, Kaohsiung Veterans General Hospital, 386 Ta-Chung 1st Road, Kaohsiung 813, Taiwan. Tel: +886-7-3468299; Fax: +886-7-3468292; E-mail: hctsai1011{at}yahoo.com.tw

Keywords: methicillin-resistant Staphylococcus aureus , definitions , S. aureus

Sir,

Although community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) have distinct microbiological, epidemiological and molecular characteristics different from those of healthcare-associated MRSA (HA-MRSA), currently, there are no validated definitions for CA-MRSA. We read with interest the newly proposed definitions published by Millar et al.1 In their article, comparing the differences between CA-MRSA and HA-MRSA, the authors also reviewed all published cases of CA-MRSA endocarditis to date.

There are several errors in the article by Millar et al.1 First, of the 23 patients with infective endocarditis due to CA-MRSA, 2 of the 7 cases in the Haque2 series (Cases 3 and 7) were in fact healthcare-associated, although all 7 cases were Panton–Valentine leucocidin (PVL)-positive and carried the SCCmecA type IV gene. In Taiwan, the most common SCCmec types in CA-MRSA infections were types IV and VT.35 MRSA colonized a substantial proportion of healthy children and accounted for 25% to 75% of the childhood CA-MRSA infections.3,4 However, SCCmec type IV can also be hospital-acquired and accounted for 40% to 43% of MRSA infections in two studies.4,6 This suggests that SCCmec type IV alone is not sufficient to indicate community acquisition and should not be the only criterion for CA-MRSA.

Secondly, in the table comparing clinical characteristics and outcome for patients with methicillin-susceptible S. aureus (MSSA) native valve endocarditis with those of MRSA and CA-MRSA native valve endocarditis (Table 3), it is unclear why only 81% of the CA-MRSA was community-acquired. What then is the definition of CA-MRSA if it does not satisfy the criteria of ‘community acquisition’?

We concur with the authors that emergence of CA-MRSA infection impacts significantly on the outcome and management of infective endocarditis. However, a comprehensive definition of CA-MRSA is still currently lacking, reflecting the complexity of this pathogen in its clinical, epidemiological and microbiological characteristics. We caution that a combination of characteristics, rather than a single one (such as SCCmec type IV genotype), should be used to define CA-MRSA.


    Transparency declarations
 Top
 Transparency declarations
 References
 
None to declare.


    References
 Top
 Transparency declarations
 References
 
1 Millar BC, Prendergast BD, Moore JE. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother (2008) 61:1–7.[Abstract/Free Full Text]

2 Haque NZ, Davis SL, Manierski CL, et al. Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2007) 30:72–7.[CrossRef][Web of Science][Medline]

3 Chen CJ, Huang YC. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. J Microbiol Immunol Infect (2005) 38:376–82.[Medline]

4 Chen CJ, Huang YC, Chiu CH, et al. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J (2005) 24:40–5.[CrossRef][Web of Science][Medline]

5 Boyle-Vavra S, Ereshefsky B, Wang CC, et al. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol (2005) 43:4719–30.[Abstract/Free Full Text]

6 Huang YH, Tseng SP, Hu JM, et al. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect (2007) 13:717–24.[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
B. C. Millar, B. D. Prendergast, and J. E. Moore
Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis--authors' response
J. Antimicrob. Chemother., April 1, 2008; 61(4): 967 - 968.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/4/966    most recent
dkn061v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tsai, H.-C.
Right arrow Articles by Liu, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, H.-C.
Right arrow Articles by Liu, Y.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?